Guidelines for diagnosis and treatment of patients with vasospastic angina (Coronary Spastic Angina) (JCS 2013).

lines for Diagnosis and Treatment of Patients with Vasospastic Angina (Coronary Spastic Angina)” in 20085 and a digest version of the guidelines in English in 2010.6 In 2012, the JCS decided to revise the guidelines to reflect the findings obtained since the publication of the first version. The first guidelines were prepared by the Joint Working Groups consisting of members recommended by six academic societies, i.e., the JCS, the Japanese Coronary Association, the Japanese Association for Thoracic Surgery, the Japanese Association of Cardiovascular Intervention and Therapeutics, the Japanese College of Cardiology, and the Japanese Society for Cardiovascular Surgery. In the preparation of the revised version, some members were changed and new members from the Japanese Association of Cardioangioscopy participated in the Joint Working Groups. In April 2012, the Joint Working Groups, consisting of 21 members and 15 collaborators who have been at the forefront of research and clinical practice for the diagnosis and treat

[1]  S. Akin,et al.  A Broken Heart , 2014, Journal of cardiac surgery.

[2]  S. Hokimoto,et al.  Coronary Vasomotor Response to Intracoronary Acetylcholine Injection, Clinical Features, and Long‐term Prognosis in 873 Consecutive Patients With Coronary Spasm: Analysis of a Single‐Center Study Over 20 Years , 2013, Journal of the American Heart Association.

[3]  H. Shimokawa,et al.  Clinical implications of provocation tests for coronary artery spasm: safety, arrhythmic complications, and prognostic impact: multicentre registry study of the Japanese Coronary Spasm Association. , 2013, European heart journal.

[4]  M. Shoda,et al.  Guidelines for Non-Pharmacotherapy of Cardiac Arrhythmias (JCS 2011). , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[5]  M. Nishizaki,et al.  Clinical implications of an implantable cardioverter-defibrillator in patients with vasospastic angina and lethal ventricular arrhythmia. , 2012, Journal of the American College of Cardiology.

[6]  K. Kaikita,et al.  Significance of coronary vasospasm in the perioperative management of non-cardiac surgery. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[7]  HiroakiMatsubara,et al.  Coronary Vasospasm Induced in Transgenic Mouse With Increased Phospholipase C-δ1 Activity , 2012 .

[8]  J. Kaski,et al.  High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries). , 2012, Journal of the American College of Cardiology.

[9]  M. Kawai,et al.  Severe lasting coronary spasm detected by multi-detector row computed tomography. , 2011, International journal of cardiology.

[10]  G. Watanabe,et al.  Intraradial administration of fasudil inhibits augmented Rho kinase activity to effectively dilate the spastic radial artery during coronary artery bypass grafting surgery. , 2011, The Journal of thoracic and cardiovascular surgery.

[11]  G. Schuler,et al.  Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. , 2011, JAMA.

[12]  K. Kitamura,et al.  The impact of Rho-kinase inhibitor, “Fasudil”, intracoronary bolus administration to improve refractory coronary vasospasm , 2011, Cardiovascular intervention and therapeutics.

[13]  H. Shimokawa,et al.  Clinical Characteristics and Long-Term Prognosis of Vasospastic Angina Patients Who Survived Out-of-Hospital Cardiac Arrest: Multicenter Registry Study of the Japanese Coronary Spasm Association , 2011, Circulation. Arrhythmia and electrophysiology.

[14]  T. Münzel,et al.  Nitrate therapy: new aspects concerning molecular action and tolerance. , 2011, Circulation.

[15]  K. Chayama,et al.  Calcium channel blocker and Rho-associated kinase activity in patients with hypertension , 2011, Journal of hypertension.

[16]  K. Okumura,et al.  Comparison of the effects of long-acting nifedipine CR and diltiazem R in patients with vasospastic angina: Aomori coronary spastic angina study. , 2010, Journal of cardiology.

[17]  H. Shimokawa,et al.  Prognostic effects of calcium channel blockers in patients with vasospastic angina--a meta-analysis. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[18]  T. Akasaka,et al.  Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2008): digest version. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[19]  S. Umemura,et al.  Simple and accurate electrocardiographic criteria to differentiate takotsubo cardiomyopathy from anterior acute myocardial infarction. , 2010, Journal of the American College of Cardiology.

[20]  S. Umemura,et al.  Digital assessment of endothelial function and ischemic heart disease in women. , 2010, Journal of the American College of Cardiology.

[21]  C. Glueck,et al.  Endothelial nitric oxide synthase T-786C mutation, a reversible etiology of Prinzmetal's angina pectoris. , 2010, The American journal of cardiology.

[22]  Masato Nakamura,et al.  Effects of treatment with once-daily nifedipine CR and twice-daily benidipine on prevention of symptomatic attacks in patients with coronary spastic angina pectoris-Adalat Trial vs Coniel in Tokyo against Coronary Spastic Angina (ATTACK CSA). , 2010, Journal of cardiology.

[23]  Kenta Ito,et al.  Role of Rho-kinase in the pathogenesis of coronary hyperconstricting responses induced by drug-eluting stents in pigs in vivo. , 2009, Journal of the American College of Cardiology.

[24]  M. Yoshimura,et al.  Severe coronary spasm occasionally detected by coronary computed tomography. , 2009, European heart journal.

[25]  J. Lambert,et al.  Association of ornithine transcarbamylase gene polymorphisms with hypertension and coronary artery vasomotion. , 2009, American journal of hypertension.

[26]  A. Takeshita,et al.  Rho-kinase is an important therapeutic target in cardiovascular medicine. , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[27]  O. Muller,et al.  Interference of Drug-Eluting Stents With Endothelium-Dependent Coronary Vasomotion: Evidence for Device-Specific Responses , 2008, Circulation. Cardiovascular interventions.

[28]  U. Sechtem,et al.  Coronary artery spasm as a frequent cause of acute coronary syndrome: The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study. , 2008, Journal of the American College of Cardiology.

[29]  H. Kishida,et al.  Administration of the Rho-kinase inhibitor, fasudil, following nitroglycerin additionally dilates the site of coronary spasm in patients with vasospastic angina , 2008, Coronary artery disease.

[30]  T. Nakata,et al.  Clinical implications of midventricular obstruction and intravenous propranolol use in transient left ventricular apical ballooning (Tako-tsubo cardiomyopathy). , 2008, American heart journal.

[31]  M. Mishima,et al.  Intracoronary nicorandil relieves multiple coronary vasospasm with hemodynamic collapse. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[32]  K. Kaikita,et al.  A novel genetic marker for coronary spasm in women from a genome-wide single nucleotide polymorphism analysis , 2007, Pharmacogenetics and genomics.

[33]  T. Sakamoto,et al.  Successful treatment of refractory angina pectoris due to multivessel coronary spasm with valsartan. , 2007, Internal medicine.

[34]  K. Nakao,et al.  The endothelial nitric oxide synthase gene -786T/C polymorphism is a predictive factor for reattacks of coronary spasm , 2007, Pharmacogenetics and genomics.

[35]  Deepak L. Bhatt,et al.  One-year cardiovascular event rates in outpatients with atherothrombosis. , 2007, JAMA.

[36]  K. Maekawa,et al.  Impaired endothelial vasomotor function after sirolimus-eluting stent implantation. , 2007, Circulation journal : official journal of the Japanese Circulation Society.

[37]  H. Ogawa,et al.  Prognostic value of flow-mediated dilation of the brachial artery in patients with cardiovascular disease. , 2006, Internal medicine.

[38]  P. Fitzgerald,et al.  Location of focal vasospasm provoked by ergonovine maleate within coronary arteries in patients with vasospastic angina pectoris. , 2006, The American journal of cardiology.

[39]  H. Ogawa,et al.  Sex differences of risk factors for acute myocardial infarction in Japanese patients. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[40]  H. Kishida,et al.  Vasodilatory effect of subsequent administration of fasudil, a rho-kinase inhibitor, surpasses that of nitroglycerin at the concentric coronary stenosis in patients with stable angina pectoris. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[41]  J. Taguchi,et al.  Coronary artery spasm and the polymorphisms of the endothelial nitric oxide synthase gene. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[42]  K. Sunagawa,et al.  Coronary Microvascular Dysfunction in Patients With Microvascular Angina: Analysis by TIMI Frame Count , 2005, Journal of cardiovascular pharmacology.

[43]  H. Fukuda,et al.  Need for documentation of guidelines for coronary artery spasm: an investigation by questionnaire in Japan. , 2005, Circulation journal : official journal of the Japanese Circulation Society.

[44]  B. Cannon,et al.  Nitric Oxide in the Evaluation of Congenital Heart Disease with Pulmonary Hypertension: Factors Related to Nitric Oxide Response , 2005, Pediatric Cardiology.

[45]  O. Hess,et al.  Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. , 2005, Journal of the American College of Cardiology.

[46]  K. Nakao,et al.  Increase in the transcriptional activity of the endothelial nitric oxide synthase gene with fluvastatin: a relation with the −786T>C polymorphism , 2005, Pharmacogenetics and genomics.

[47]  Katherine C. Wu,et al.  Neurohumoral features of myocardial stunning due to sudden emotional stress. , 2005, The New England journal of medicine.

[48]  K. Iida,et al.  Prognostic value of I-123 metaiodobenzylguanidine imaging in vasospastic angina without significant coronary stenosis. , 2005, Circulation journal : official journal of the Japanese Circulation Society.

[49]  Jin Won Kim,et al.  Delayed severe multivessel spasm and aborted sudden death after Taxus stent implantation , 2005, Heart.

[50]  A. Lerman,et al.  Systematic Review: Transient Left Ventricular Apical Ballooning: A Syndrome That Mimics ST-Segment Elevation Myocardial Infarction , 2004, Annals of Internal Medicine.

[51]  H. Shimokawa,et al.  Changing Characteristics of Patients with Vasospastic Angina in the Era of New Calcium Channel Blockers , 2004, Journal of cardiovascular pharmacology.

[52]  H. Shimokawa,et al.  Usefulness of Fasudil, a Rho-kinase Inhibitor, to Treat Intractable Severe Coronary Spasm after Coronary Artery Bypass Surgery , 2004, Journal of cardiovascular pharmacology.

[53]  H. Fukuda,et al.  Frequency of Provoked Coronary Spasms in Patients Undergoing Coronary Arteriography Using a Spasm Provocation Test Via Intracoronary Administration of Ergonovine , 2004, Angiology.

[54]  H. Ogawa,et al.  Endothelial dysfunction and coronary artery spasm. , 2004, Current drug targets. Cardiovascular & haematological disorders.

[55]  HiroakiShimokawa,et al.  Evidence for Protein Kinase C-Mediated Activation of Rho- Kinase in a Porcine Model of Coronary Artery Spasm , 2003 .

[56]  J. Koyama,et al.  Plaque morphology at coronary sites with focal spasm in variant angina: study using intravascular ultrasound. , 2003, Circulation journal : official journal of the Japanese Circulation Society.

[57]  K. Nakao,et al.  Synergistic interaction of T-786-->C polymorphism in the endothelial nitric oxide synthase gene and smoking for an enhanced risk for coronary spasm. , 2003, Pharmacogenetics.

[58]  J. Yodoi,et al.  Attenuation of Nitrate Tolerance and Oxidative Stress by an Angiotensin II Receptor Blocker in Patients With Coronary Spastic Angina , 2003, Circulation.

[59]  I. Palacios,et al.  Apical ballooning of the left ventricle: first series in white patients , 2003, Heart.

[60]  Fernando Costa,et al.  Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Ph , 2003, Circulation.

[61]  Y. Nishimura,et al.  Preference Toward a T-Helper Type 1 Response in Patients With Coronary Spastic Angina , 2003, Circulation.

[62]  A. Steptoe,et al.  Systematic review of mental stress-induced myocardial ischaemia. , 2003, European heart journal.

[63]  M. Kondo,et al.  Assessment of clinical features in transient left ventricular apical ballooning. , 2003, Journal of the American College of Cardiology.

[64]  K. Miwa Low density lipoprotein particles are small in patients with coronary vasospasm. , 2003, International journal of cardiology.

[65]  K. Nishioka,et al.  Usefulness of massive oral nicorandil in a patient with variant angina refractory to conventional treatment. , 2003, Internal medicine.

[66]  N. Kanagy,et al.  Acute and chronic NOS inhibition enhances alpha(2)- adrenoreceptor-stimulated RhoA and Rho kinase in rat aorta. , 2002, American journal of physiology. Heart and circulatory physiology.

[67]  C. Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[68]  N. Ochi,et al.  New protocol to detect coronary spastic angina without fixed stenosis. , 2002, Japanese heart journal.

[69]  R. Karas,et al.  The protective effects of estrogen on the cardiovascular system. , 2002, The New England journal of medicine.

[70]  B. Strasberg,et al.  Usefulness of implantable cardioverter-defibrillators in refractory variant angina pectoris complicated by ventricular fibrillation in patients with angiographically normal coronary arteries. , 2002, The American journal of cardiology.

[71]  H. Tomita,et al.  Enhanced Activity of Variant Phospholipase C-&dgr;1 Protein (R257H) Detected in Patients With Coronary Artery Spasm , 2002, Circulation.

[72]  Masahiro Ito,et al.  Limited role of coronary angioplasty and stenting in coronary spastic angina with organic stenosis. , 2002, Journal of the American College of Cardiology.

[73]  A. Takeshita,et al.  Suppression of Coronary Artery Spasm by the Rho-Kinase Inhibitor Fasudil in Patients With Vasospastic Angina , 2002, Circulation.

[74]  K. Kugiyama,et al.  Endothelial function fluctuates with diurnal variation in the frequency of ischemic episodes in patients with variant angina. , 2002, Journal of the American College of Cardiology.

[75]  A. Takeshita,et al.  Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina. , 2002, Journal of the American College of Cardiology.

[76]  K. Nishioka,et al.  Tako-tsubo-like left ventricular dysfunction with ST-segment elevation: a novel cardiac syndrome mimicking acute myocardial infarction. , 2002, American heart journal.

[77]  E. Benjamin,et al.  Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. , 2002, Journal of the American College of Cardiology.

[78]  K. Kugiyama,et al.  Menstrual Cyclic Variation of Myocardial Ischemia in Premenopausal Women with Variant Angina , 2001, Annals of Internal Medicine.

[79]  A. Takeshita,et al.  Three-year follow-up of the Japanese patients with microvascular angina attributable to coronary microvascular spasm. , 2001, International journal of cardiology.

[80]  W. Sessa,et al.  Acidic Hydrolysis as a Mechanism for the Cleavage of the Glu298 → Asp Variant of Human Endothelial Nitric-oxide Synthase* , 2001, The Journal of Biological Chemistry.

[81]  H. Ogawa,et al.  Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. Angina Pectoris-Myocardial Infarction Investigations in Japan. , 2001, Journal of the American College of Cardiology.

[82]  G. He,et al.  Arterial grafts for coronary surgery: vasospasm and patency rate. , 2001, The Journal of thoracic and cardiovascular surgery.

[83]  K. Kugiyama,et al.  Estradiol supplementation suppresses hyperventilation-induced attacks in postmenopausal women with variant angina. , 2001, Journal of the American College of Cardiology.

[84]  H. Ishizaka,et al.  Enhanced phospholipase C activity in the cultured skin fibroblast obtained from patients with coronary spastic angina: possible role for enhanced vasoconstrictor response. , 2000, Journal of the American College of Cardiology.

[85]  K. Kangawa,et al.  Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a -786T-->C mutation associated with coronary spastic angina. , 2000, Human molecular genetics.

[86]  K. Kaibuchi,et al.  Rho-Kinase Is Involved in Macrophage-Mediated Formation of Coronary Vascular Lesions in Pigs In Vivo , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[87]  K. Nakao,et al.  T(-786)--> C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with myocardial infarction, especially without coronary organic stenosis. , 2000, The American journal of cardiology.

[88]  R. Erbel,et al.  Safety of intracoronary Doppler flow measurement. , 2000, American heart journal.

[89]  Seung‐Jung Park,et al.  Intravascular ultrasound findings of negative arterial remodeling at sites of focal coronary spasm in patients with vasospastic angina. , 2000, American Heart Journal.

[90]  S. Fichtlscherer,et al.  Elevated C-Reactive Protein Levels and Impaired Endothelial Vasoreactivity in Patients With Coronary Artery Disease , 2000, Circulation.

[91]  K. Kugiyama,et al.  Diffuse intimal thickening of coronary arteries in patients with coronary spastic angina. , 2000, Journal of the American College of Cardiology.

[92]  K. Kugiyama,et al.  Improvement of endothelial function and insulin sensitivity with vitamin C in patients with coronary spastic angina: possible role of reactive oxygen species. , 2000, Journal of the American College of Cardiology.

[93]  S. Yasuda,et al.  Refractory coronary spasm relieved by intracoronary administration of nicorandil. , 2000, Japanese circulation journal.

[94]  J. Moss,et al.  Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[95]  R. Mongiardo,et al.  Major racial differences in coronary constrictor response between japanese and caucasians with recent myocardial infarction. , 2000, Circulation.

[96]  K. Suzuki,et al.  [Multi-vasospastic angina refractory to medical therapy caused by hyperthyroid stage of chronic thyroiditis and hypereosinophilia: a case report]. , 2000, Journal of cardiology.

[97]  H. Sakuragi,et al.  Acetylcholine‐ and ergonovine‐induced coronary microvascular spasm reflected by increased coronary vascular resistance and myocardial lactate production , 2000, Clinical cardiology.

[98]  Y. Hirano,et al.  Diagnosis of vasospastic angina by hyperventilation and cold-pressor stress echocardiography: comparison to I-MIBG myocardial scintigraphy. , 2000, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[99]  K. Kugiyama,et al.  Comparison of the risk factors for coronary artery spasm with those for organic stenosis in a Japanese population: role of cigarette smoking. , 2000, International journal of cardiology.

[100]  H. Takaoka,et al.  Systemic endothelial function is preserved in men with both active and inactive variant angina pectoris. , 1999, The American journal of cardiology.

[101]  G. Newton,et al.  Long-term endothelial dysfunction after coronary artery stenting. , 1999, Journal of the American College of Cardiology.

[102]  A. Takeshita,et al.  Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. , 1999, Cardiovascular research.

[103]  J. Alpert,et al.  ACC/AHA guidelines for ambulatory electrocardiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to revise the guidelines for ambulatory electrocardiography). , 1999, Circulation.

[104]  T. Utsunomiya,et al.  Mental stress test is an effective inducer of vasospastic angina pectoris: comparison with cold pressor, hyperventilation and master two-step exercise test. , 1999, International journal of cardiology.

[105]  R. Busse,et al.  Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation , 1999, Nature.

[106]  K. Nakao,et al.  T-786-->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. , 1999, Circulation.

[107]  A. Maseri,et al.  Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients. , 1999, Journal of the American College of Cardiology.

[108]  N. Ochi,et al.  Frequency of provoked coronary vasospasm in patients undergoing coronary arteriography with spasm provocation test of acetylcholine. , 1999, The American journal of cardiology.

[109]  P. Dendale,et al.  Prinzmetal's variant angina: three case reports and a review of the literature. , 1999, Acta cardiologica.

[110]  Masahiro Ito,et al.  Abnormal fatty acid metabolism in patients with coronary vasospasm , 1999, Annals of nuclear medicine.

[111]  N. Ochi,et al.  Investigation of the most effective provocation test for patients with coronary spastic angina: usefulness of accelerated exercise following hyperventilation. , 1999, Japanese circulation journal.

[112]  K. Kugiyama,et al.  Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. , 1998, Journal of the American College of Cardiology.

[113]  K. Urabe,et al.  Inappropriate microvascular constriction produced transient ST-segment elevation in patients with syndrome X. , 1998, Journal of the American College of Cardiology.

[114]  K. Nakao,et al.  A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese , 1998, Human Genetics.

[115]  E. Vittinghoff,et al.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. , 1998, JAMA.

[116]  T. Kondo,et al.  [Clinical differences between variant and non-variant angina pectoris]. , 1998, Journal of cardiology.

[117]  K. Kugiyama,et al.  Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina. , 1998, Journal of the American College of Cardiology.

[118]  C. Herzog,et al.  Reversible myocardial contraction abnormalities in patients with an acute noncardiac illness. , 1998, Chest.

[119]  H. Inoue,et al.  Alterations of autonomic nervous activity preceding nocturnal variant angina: sympathetic augmentation with parasympathetic impairment. , 1998, American heart journal.

[120]  A. Takeshita,et al.  Angina pectoris caused by coronary microvascular spasm , 1998, The Lancet.

[121]  K. Nakajima,et al.  Value of iodine-123 metaiodobenzylguanidine scintigraphy in patients with vasospastic angina , 1998, European Journal of Nuclear Medicine.

[122]  T. Kurosawa,et al.  Sudden cardiac death in Japanese people aged 20-60 years--an autopsy study of 133 cases. , 1997, Japanese circulation journal.

[123]  K. Kugiyama,et al.  Coronary spasm: clinical features and pathogenesis. , 1997, Internal medicine.

[124]  D. Pavin,et al.  Human stress cardiomyopathy mimicking acute myocardial syndrome , 1997, Heart.

[125]  K. Kugiyama,et al.  Gender difference in improvement of endothelium-dependent vasodilation after estrogen supplementation. , 1997, Journal of the American College of Cardiology.

[126]  K. Nakao,et al.  Hyperventilation as a specific test for diagnosis of coronary artery spasm. , 1997, The American journal of cardiology.

[127]  K. Kugiyama,et al.  Long-lasting abnormalities in cardiac sympathetic nervous system in patients with coronary spastic angina: quantitative analysis with iodine 123 metaiodobenzylguanidine myocardial scintigraphy. , 1997, American heart journal.

[128]  M. Shirotani,et al.  Assessment of regional sympathetic nerve activity in vasospastic angina: analysis of iodine 123-labeled metaiodobenzylguanidine scintigraphy. , 1997, American heart journal.

[129]  K. Kugiyama,et al.  Supersensitive dilator response to nitroglycerin but not to atrial natriuretic peptide in spastic coronary arteries in coronary spastic angina. , 1997, The American journal of cardiology.

[130]  K. Hirata,et al.  Disparity between serotonin‐ and acetylcholine‐provoked coronary artery Spasm , 1997, Clinical cardiology.

[131]  K. Kugiyama,et al.  Menstrual cyclic variation of endothelium-dependent vasodilation of the brachial artery: possible role of estrogen and nitric oxide. , 1996, Proceedings of the Association of American Physicians.

[132]  K. Morgan,et al.  Mechanisms of smooth muscle contraction. , 1996, Physiological reviews.

[133]  Yoshiharu Matsuura,et al.  Phosphorylation and Activation of Myosin by Rho-associated Kinase (Rho-kinase)* , 1996, The Journal of Biological Chemistry.

[134]  K. Nakao,et al.  Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. , 1996, Circulation.

[135]  Kozo Kaibuchi,et al.  Regulation of Myosin Phosphatase by Rho and Rho-Associated Kinase (Rho-Kinase) , 1996, Science.

[136]  H. Inoue,et al.  Vitamin E deficiency in variant angina. , 1996, Circulation.

[137]  M. Mazzari,et al.  Low incidence of serotonin-induced occlusive coronary artery spasm in patients with recent myocardial infarction. , 1996, The American journal of cardiology.

[138]  T. Murohara,et al.  Effects of angiotensin-converting enzyme inhibitor alacepril in patients with stable effort angina during chronic isosorbide dinitrate treatment. , 1996, The American journal of cardiology.

[139]  A. Logan,et al.  Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. , 1996, JAMA.

[140]  T. Kakuta,et al.  Impaired glucose tolerance with late hypersecretion of insulin during oral glucose tolerance test in patients with vasospastic angina. , 1996, Journal of the American College of Cardiology.

[141]  J. Deanfield,et al.  Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. , 1996, The New England journal of medicine.

[142]  P. Serruys,et al.  Progression and regression of coronary stenosis in the long-term follow-up of vasospastic angina. , 1995, Circulation.

[143]  K. Nakajima,et al.  Utility of iodine-123-BMIPP in the diagnosis and follow-up of vasospastic angina. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[144]  K. Okumura,et al.  Soluble P-selectin is released into the coronary circulation after coronary spasm. , 1995, Circulation.

[145]  H. Takaki,et al.  Insulin resistance associated with compensatory hyperinsulinemia as an independent risk factor for vasospastic angina. , 1995, Circulation.

[146]  J. Koyama,et al.  Comparison of vessel wall morphologic appearance at sites of focal and diffuse coronary vasospasm by intravascular ultrasound. , 1995, American heart journal.

[147]  M. Fujita,et al.  Susceptibility of plasma low density lipoprotein to cupric ion-induced peroxidation in patients with variant angina. , 1995, Journal of the American College of Cardiology.

[148]  Y. Itai,et al.  Usefulness of hyperventilation thallium-201 single photon emission computed tomography for the diagnosis of vasospastic angina. , 1995, Japanese heart journal.

[149]  W E Haefeli,et al.  Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. , 1995, Circulation.

[150]  H. Takano,et al.  Regional myocardial sympathetic dysinnervation in patients with coronary vasospasm. , 1995, The American journal of cardiology.

[151]  Satoshi Higa,et al.  Enhanced insulin response relates to acetylcholine-induced vasoconstriction in vasospastic angina. , 1995, Journal of the American College of Cardiology.

[152]  A. J. Wells Passive smoking as a cause of heart disease. , 1994, Journal of the American College of Cardiology.

[153]  A. Nitenberg,et al.  Coronary artery constriction caused by the cold pressor test in human hypertension. , 1994, Hypertension.

[154]  D. Spiegelhalter,et al.  Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. , 1994, Journal of the American College of Cardiology.

[155]  A. Tsubokawa,et al.  [Induction of coronary artery spasm by combined cold pressor and hyperventilation test in patients with variant angina]. , 1994, Journal of cardiology.

[156]  K. Kugiyama,et al.  Comparison of the distribution of myocardial blood flow between exercise-induced and hyperventilation-induced attacks of coronary spasm: a study with thallium-201 myocardial scintigraphy. , 1994, American heart journal.

[157]  T. Hoshino,et al.  Assessment of quantitative exercise thallium-201 emission computed tomography in patients with vasospastic angina--value of washout rate analysis. , 1994, Japanese circulation journal.

[158]  K. Kugiyama,et al.  Influence of exercise-induced coronary artery spasm on thallium-201 initial distribution and washout kinetics in patients with variant and classic angina pectoris. , 1994, The American journal of cardiology.

[159]  J. Isner,et al.  Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. , 1994, Circulation.

[160]  M. Fujita,et al.  Beneficial effects of smoking cessation on the short-term prognosis for variant angina--validation of the smoking status by urinary cotinine measurements. , 1994, International journal of cardiology.

[161]  J. Koyama,et al.  Intravascular ultrasound detection of atherosclerosis at the site of focal vasospasm in angiographically normal or minimally narrowed coronary segments. , 1994, Journal of the American College of Cardiology.

[162]  K. Mizuno,et al.  Angioscopy in variant angina: coronary artery spasm and intimal injury , 1993, The Lancet.

[163]  K. Okumura,et al.  Increased plasma plasminogen activator inhibitor activity after coronary spasm. , 1993, International journal of cardiology.

[164]  A. Takeshita,et al.  Clinical characteristics of patients with spontaneous remission of variant angina. , 1993, Japanese circulation journal.

[165]  T. Giles,et al.  Randomized placebo-controlled trial of amlodipine in vasospastic angina. Amlodipine Study 160 Group. , 1993, Journal of the American College of Cardiology.

[166]  F. Takatsu,et al.  Cigarette Smoking Is a Major Risk Factor for Coronary Spasm , 1993, Circulation.

[167]  C. Hanet,et al.  Vasomotor Response to Ergometrine and Nitrates of Saphenous Vein Grafts, Internal Mammary Artery Grafts, and Grafted Coronary Arteries Late After Bypass Surgery , 1992, Circulation.

[168]  T. Nakamura,et al.  Statistical analysis of clinical risk factors for coronary artery spasm: identification of the most important determinant. , 1992, American Heart Journal.

[169]  D. Pryor,et al.  Ergonovine maleate testing during cardiac catheterization: a 10-year perspective in 3,447 patients without significant coronary artery disease or Prinzmetal's variant angina. , 1992, Journal of the American College of Cardiology.

[170]  K. Okumura,et al.  Effect of acetylcholine on the highly stenotic coronary artery: difference between the constrictor response of the infarct-related coronary artery and that of the noninfarct-related artery. , 1992, Journal of the American College of Cardiology.

[171]  M. Kern,et al.  Smoking Is a Risk Factor for Coronary Spasm in Young Women , 1992, Circulation.

[172]  K. Mizuno,et al.  Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. , 1992, The New England journal of medicine.

[173]  J P Cooke,et al.  Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. , 1991, The Journal of clinical investigation.

[174]  K. Nakao,et al.  Increased plasma level of endothelin-1-like immunoreactivity during coronary spasm in patients with coronary spastic angina. , 1991, The American journal of cardiology.

[175]  M. Nobuyoshi,et al.  Progression of coronary atherosclerosis: is coronary spasm related to progression? , 1991, Journal of the American College of Cardiology.

[176]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[177]  K. Mizuno,et al.  Angioscopic coronary macromorphology in patients with acute coronary disorders , 1991, The Lancet.

[178]  K. Okumura,et al.  Fibrinopeptide A is released into the coronary circulation after coronary spasm. , 1990, Circulation.

[179]  K. Kugiyama,et al.  Coronary artery spasm: Japanese view , 1990 .

[180]  K. Hirata,et al.  Supersensitivity of isolated coronary artery to ergonovine in a patient with variant angina. , 1990, The American journal of medicine.

[181]  K. Kugiyama,et al.  Magnesium deficiency detected by intravenous loading test in variant angina pectoris. , 1990, The American journal of cardiology.

[182]  A. Takeshita,et al.  Exercise-induced silent myocardial ischemia in patients with vasospastic angina. , 1990, American heart journal.

[183]  K. Okumura,et al.  Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Possible role of early coronary atherosclerosis. , 1990, Circulation.

[184]  D. Martínez-Caro,et al.  The value of exercise testing in patients with coronary artery spasm. , 1990, American heart journal.

[185]  A. Takeshita,et al.  Clinical characteristics of sudden cardiac death in patients with vasospastic angina. , 1989, Japanese circulation journal.

[186]  K. Okumura,et al.  Circadian variation of plasma fibrinopeptide A level in patients with variant angina. , 1989, Circulation.

[187]  D. Ardissino,et al.  Hyperventilation and ergonovine tests in Prinzmetal's variant angina: comparative sensitivity and relation with the activity of the disease. , 1989, European heart journal.

[188]  G. V. R. Born,et al.  INFLUENCE OF PLAQUE CONFIGURATION AND STRESS DISTRIBUTION ON FISSURING OF CORONARY ATHEROSCLEROTIC PLAQUES , 1989, The Lancet.

[189]  H. Drexler,et al.  Flow-dependent coronary artery dilatation in humans. , 1989, Circulation.

[190]  L. Ignarro,et al.  Biological Actions and Properties of Endothelium-Derived Nitric Oxide Formed and Released From Artery and Vein , 1989, Circulation research.

[191]  T. Aizawa,et al.  Effect of nicorandil on coronary spasm. , 1989, The American journal of cardiology.

[192]  K. Okumura,et al.  Effect of magnesium on anginal attack induced by hyperventilation in patients with variant angina. , 1989, Circulation.

[193]  K. Okumura,et al.  Hyperventilation-induced simultaneous multivessel coronary spasm in patients with variant angina: an echocardiographic and arteriographic study. , 1988, Journal of the American College of Cardiology.

[194]  K. Okumura,et al.  Sensitivity and specificity of intracoronary injection of acetylcholine for the induction of coronary artery spasm. , 1988, Journal of the American College of Cardiology.

[195]  M. Horie,et al.  Long-term prognosis for patients with variant angina and influential factors. , 1988, Circulation.

[196]  F. Zak,et al.  Morphodynamic Interpretation of Acute Coronary Thrombosis, with Special Reference to Volcano-Like Eruption of Atheromatous Plaque Caused by Coronary Artery Spasm , 1988, Angiology.

[197]  K. Kugiyama,et al.  Multivessel coronary spasm in patients with variant angina: a study with intracoronary injection of acetylcholine. , 1988, Circulation.

[198]  M. Nakamura,et al.  Clinical characteristics and long-term prognosis of patients with variant angina. A comparative study between western and Japanese populations. , 1988, International journal of cardiology.

[199]  H. Yasue,et al.  Possible role of coronary spasm in acute myocardial infarction precipitated by hyperventilation. , 1988, British heart journal.

[200]  D. Waters,et al.  Long-term prognosis of patients with variant angina. , 1987, Circulation.

[201]  J. Azuma,et al.  Usefulness of Isosorbide Dinitrate Spray as an Angina Attack Relieving Agent , 1987 .

[202]  A. Takeshita,et al.  Clinical characteristics associated with myocardial infarction, arrhythmias, and sudden death in patients with vasospastic angina. , 1987, Circulation.

[203]  A. Madeo,et al.  Efficacy of diltiazem in variant angina. Results of a double-blind crossover study in CCU by Holter monitoring. The possible occurrence of a withdrawal syndrome. , 1987, Giornale italiano di cardiologia.

[204]  S. Chierchia,et al.  Induction of coronary artery spasm by a direct local action of ergonovine. , 1987, Circulation.

[205]  R. Krone,et al.  Comparison of electrocardiography and thallium-201 myocardial scintigraphy for the detection of ergonovine-induced coronary artery spasm: angiographic correlation. , 1987, American heart journal.

[206]  T. Takakuwa,et al.  [Clinical application of intracoronary administration of ergonovine for detecting vasospastic angina]. , 1987, Kokyu to junkan. Respiration & circulation.

[207]  F. Crea,et al.  Local coronary supersensitivity to diverse vasoconstrictive stimuli in patients with variant angina. , 1986, Circulation.

[208]  K. Kugiyama,et al.  Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. , 1986, Circulation.

[209]  M. Nakamura,et al.  Histamine-induced coronary spasm in regions of intimal thickening in miniature pigs: roles of serum cholesterol and spontaneous or induced intimal thickening. , 1986, Circulation.

[210]  M. Bertrand,et al.  Comparative results of percutaneous transluminal coronary angioplasty in patients with dynamic versus fixed coronary stenosis. , 1986, Journal of the American College of Cardiology.

[211]  F. Crea,et al.  Different susceptibility to myocardial ischemia provoked by hyperventilation and cold pressor test in exertional and variant angina pectoris. , 1985, The American journal of cardiology.

[212]  D. Waters,et al.  Percutaneous transluminal coronary angioplasty for the treatment of variant angina. , 1985, Journal of the American College of Cardiology.

[213]  F E Harrell,et al.  Clinical characteristics and long-term survival of patients with variant angina. , 1984, Circulation.

[214]  M. Nakazawa,et al.  Mechanism of relaxant effects of nicorandil on the dog coronary artery. , 1983, Archives internationales de pharmacodynamie et de therapie.

[215]  M. Winniford,et al.  Verapamil for unstable angina at rest: a short-term randomized, double-blind study. , 1983, American heart journal.

[216]  K. Tanaka,et al.  Coronary artery spasm induced in atherosclerotic miniature swine. , 1983, Science.

[217]  M. Bertrand,et al.  The provocation of coronary arterial spasm in patients with recent transmural myocardial infarction. , 1983, European heart journal.

[218]  E. Falk Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. , 1983, British heart journal.

[219]  D. Waters,et al.  Factors influencing the long-term prognosis of treated patients with variant angina. , 1983, Circulation.

[220]  G. Vincent,et al.  Coronary spasm producing coronary thrombosis and myocardial infarction. , 1983, The New England journal of medicine.

[221]  H. Yasue,et al.  Coronary Arterial Spasm in Ischemic Heart Disease and Its Pathogenesis: A Review , 1983, Circulation research.

[222]  M. Bertrand,et al.  Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. , 1982, Circulation.

[223]  D. J. Hayes,et al.  Toxic effects of human eosinophil products on isolated rat heart cells in vitro. , 1982, The Biochemical journal.

[224]  J. Kaski,et al.  The hyperventilation test as a method for developing successful therapy in Prinzmetal's angina. , 1982, The American journal of cardiology.

[225]  D. Waters,et al.  Exercise Testing in Patients with Variant Angina: Results, Correlation with Clinical and Angiographic Features and Prognostic Significance , 1982, Circulation.

[226]  G. Specchia,et al.  The Exercise Test in Variant Angina: Results in 114 Patients , 1981, Circulation.

[227]  S. Vatner,et al.  Regulation of Large Coronary Arteries by Increases in Myocardial Metabolic Demands in Conscious Dogs , 1981, Circulation research.

[228]  T. Itoh,et al.  Effects of 2-nicotinamidoethyl nitrate on smooth muscle cells and on adrenergic transmission in the guinea-pig and porcine mesenteric arteries. , 1981, The Journal of pharmacology and experimental therapeutics.

[229]  T. Itoh,et al.  Vasodilating actions of 2-nicotinamidoethyl nitrate on porcine and guinea-pig coronary arteries. , 1981, The Journal of pharmacology and experimental therapeutics.

[230]  H. Kishida,et al.  Treatment of Variant Angina with Drugs: A Survey of 11 Cardiology Institutes in Japan , 1981, Circulation.

[231]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[232]  R. Miller,et al.  Provocation of Coronary Artery Spasm by the Cold Pressor Test: Hemodynamic, Arteriographic and Quantitative Angiographic Observations , 1980, Circulation.

[233]  A. Maseri,et al.  Long-term prognosis of "variant" angina with medical treatment. , 1980, The American journal of cardiology.

[234]  S. Goldberg,et al.  Refractory ergonovine-induced coronary vasospasm: importance of intracoronary nitroglycerin. , 1980, The American journal of cardiology.

[235]  R. Macalpin,et al.  Relation of coronary arterial spasm to sites of organic stenosis. , 1980, The American journal of cardiology.

[236]  E. Antman,et al.  Nifedipine therapy for coronary-artery spasm. Experience in 127 patients. , 1980, The New England journal of medicine.

[237]  G. Specchia,et al.  Coronary artery spasm of different degrees as cause of angina at rest with ST segment depression and elevation. , 1979, British heart journal.

[238]  H. Yasue,et al.  Circadian Variation of Exercise Capacity in Patients with Prinzmetal's Variant Angina: Role of Exercise‐induced Coronary Arterial Spasm , 1979, Circulation.

[239]  J. Oates,et al.  Comparative Assessment of Stimuli That Release Neuronal and Adrenomedullary Catecholamines in Man , 1979, Circulation.

[240]  J. Kastor,et al.  Coronary hemodynamic and myocardial metabolic alterations accompanying coronary spasm. , 1979, The American journal of cardiology.

[241]  C. Conti,et al.  Similarities of ergonovine-induced and spontaneous attacks of variant angina. , 1979, Circulation.

[242]  T. Ryan,et al.  ST-segment elevation during recovery from exercise. A new manifestation of Prinzmetal's variant angina. , 1978, Chest.

[243]  H. Yasue,et al.  Coronary Arterial Spasm and Prinzmetal's Variant Form of Angina Induced by Hyperventilation and Tris-buffer Infusion , 1978, Circulation.

[244]  W. Kannel,et al.  Death and coronary attacks in men after giving up cigarette smoking. A report from the Framingham study. , 1974, Lancet.

[245]  H. Yasue,et al.  Role of Autonomic Nervous System in the Pathogenesis of Prinzmetal's Variant Form of Angina , 1974, Circulation.

[246]  H. B. Sprague Emotional Factors in Coronary Heart Disease , 1961 .

[247]  M. Prinzmetal,et al.  Variant Form of Angina Pectoris: Previously Undelineated Syndrome , 1960 .

[248]  M. Prinzmetal,et al.  Angina pectoris. I. A variant form of angina pectoris; preliminary report. , 1959, The American journal of medicine.

[249]  B. Gersh 3-Year Follow-Up of Patients With Coronary Artery Spasm as Cause of Acute Coronary Syndrome: The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study Follow-Up , 2012 .

[250]  Kenta Ito,et al.  Involvement of rho-kinase activation in the pathogenesis of coronary hyperconstricting responses induced by drug-eluting stents in patients with coronary artery disease. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[251]  F. Crea,et al.  Contemporary Reviews in Cardiovascular Medicine Mechanisms of Coronary Artery Spasm , 2011 .

[252]  H. Kishida,et al.  Variant angina and coronary artery spasm: the clinical spectrum, pathophysiology, and management. , 2011, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[253]  Guidelines for Diagnosis and Treatment of Patients with Vasospastic Angina ( Coronary , 2010 .

[254]  T. Saikawa,et al.  Change in heart rate variability preceding ST elevation in a patient with vasospastic angina pectoris , 2007, Heart and Vessels.

[255]  P. Serruys,et al.  Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. , 2006, European heart journal.

[256]  K. Maekawa,et al.  Images in cardiovascular medicine. Severe endothelial dysfunction after sirolimus-eluting stent implantation. , 2006, Circulation.

[257]  H. Nonogi,et al.  Successful treatment of refractory vasospastic angina with corticosteroids: coronary arterial hyperactivity caused by local inflammation? , 2004, Circulation journal : official journal of the Japanese Circulation Society.

[258]  Hiroaki Shimokawa,et al.  Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm. , 2003, Journal of the American College of Cardiology.

[259]  K. Nakao,et al.  Genetic risk factors for coronary artery spasm: significance of endothelial nitric oxide synthase gene T-786-->C and missense Glu298Asp variants. , 2000, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[260]  T. Aizawa,et al.  Histological evaluation of coronary plaque in patients with variant angina: relationship between vasospasm and neointimal hyperplasia in primary coronary lesions. , 1999, Journal of the American College of Cardiology.

[261]  K. Hirata,et al.  5-HT1Dbeta receptor mediates the supersensitivity of isolated coronary artery to serotonin in variant angina. , 1998, Chest.

[262]  P. Touboul,et al.  Arrhythmic cardiac arrest due to isolated coronary artery spasm: long-term outcome of seven resuscitated patients. , 1998, Journal of the American College of Cardiology.

[263]  M. Okamoto,et al.  Collateral flow detected by a Doppler guide wire in a case of vasospastic angina. , 1998, Internal medicine.

[264]  H. Ishizaka,et al.  Diffuse disorder of coronary artery vasomotility in patients with coronary spastic angina. Hyperreactivity to the constrictor effects of acetylcholine and the dilator effects of nitroglycerin. , 1996, Journal of the American College of Cardiology.

[265]  R. Badenhop,et al.  A smoking–dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene , 1996, Nature Medicine.

[266]  M. Ishihara,et al.  [Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases]. , 1991, Journal of cardiology.

[267]  D. Ardissino,et al.  Hyperventilation and ergonovine tests in Prinzmetal's variant angina pectoris in men. , 1989, The American journal of cardiology.

[268]  E. Nabel,et al.  Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. , 1988, Circulation.

[269]  M. Nakamura,et al.  Effects of nicorandil on rest and effort angina unresponsive to combination therapy with a calcium antagonist and oral nitrate. , 1987, Clinical therapeutics.

[270]  M. Horie,et al.  Variant angina induced by alcohol ingestion. , 1984, American heart journal.

[271]  Y. Koga,et al.  [Risk factors of coronary spasm]. , 1983, Nihon rinsho. Japanese journal of clinical medicine.

[272]  Y. Uchida,et al.  Effect of 2-nicotinamidethyl nitrate (SG 75) on coronary circulation. , 1978, Japanese heart journal.

[273]  C. Jenkins,et al.  Coronary heart disease in the Western Collaborative Group Study. A follow-up experience of 4 and one-half years. , 1970, Journal of chronic diseases.

[274]  F. L. Hoch Thyrotoxicosis as a disease of mitochondria. , 1962, The New England journal of medicine.

[275]  W. Kannel,et al.  Cigarette smoking and coronary heart disease. Combined experience of the Albany and Framingham studies. , 1962, The New England journal of medicine.